Predicting treatment outcomes using F-FDG PET biomarkers in patients with non-small-cell lung cancer receiving chemoimmunotherapy
Background: Predictive markers for treatment response and survival outcome have not been identified in patients with advanced non-small-cell lung cancer (NSCLC) receiving chemoimmunotherapy. We aimed to evaluate whether imaging biomarkers of 18 F-fluorodeoxyglucose ( 18 F-FDG) positron emission tomo...
Main Authors: | Chang Gon Kim, Sang Hyun Hwang, Kyung Hwan Kim, Hong In Yoon, Hyo Sup Shim, Ji Hyun Lee, Yejeong Han, Beung-Chul Ahn, Min Hee Hong, Hye Ryun Kim, Byoung Chul Cho, Arthur Cho, Sun Min Lim |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2022-01-01
|
Series: | Therapeutic Advances in Medical Oncology |
Online Access: | https://doi.org/10.1177/17588359211068732 |
Similar Items
-
A phase II study of poziotinib in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
by: Ji Hyun Lee, et al.
Published: (2021-10-01) -
Distinct Characteristics and Clinical Outcomes to Predict the Emergence of <i>MET</i> Amplification in Patients with Non-Small Cell Lung Cancer Who Developed Resistance after Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
by: Beung-Chul Ahn, et al.
Published: (2021-06-01) -
Analyses of CNS Response to Osimertinib in Patients with T790M-Positive Advanced NSCLC from ASTRIS Korean Subset, Open-Label Real-World Study
by: Beung-Chul Ahn, et al.
Published: (2021-07-01) -
Detection of primary sites in unknown primary tumors using FDG-PET or FDG-PET/CT
by: Shim Young-Soo, et al.
Published: (2011-03-01) -
The Development of AXL Inhibitors in Lung Cancer: Recent Progress and Challenges
by: Yun Beom Sang, et al.
Published: (2022-03-01)